Timing note: July 31, 2026 is today, not tomorrow. This preview is framed for LYB’s 2026Q2 earnings call on July 31, 2026, prior to the company’s reported results.
LyondellBasell enters 2Q with a sharply improved operating backdrop versus 1Q, led by tighter global polymer supply, strong North American export demand, higher polyethylene (PE) and polypropylene (PP) pricing, and higher operating rates at its advantaged U.S. assets.
The central question is not whether 2Q improves sequentially—management explicitly guided to broad improvement—but rather:
A strong print likely requires evidence that O&P-Americas margins approached a much more normalized—or even peak-like—earnings level, while a more mixed outcome could result if price realization lagged, export/logistics constraints limited volumes, or Bayport downtime proved more costly than anticipated.
This is the most important segment going into the print.
In 1Q, O&P-Americas generated $327 million of EBITDA, up from $162 million in 4Q25, as polyethylene pricing and margins improved. For 2Q, management guided to:
The opportunity is substantial because LYB’s U.S. ethane-based asset base should benefit disproportionately when global, crude-linked producers are under pressure. Management also suggested that North America could shift toward greater polymer exports as supply is disrupted elsewhere.
What to watch: realized PE and PP pricing, export volumes, operating rates, and management’s commentary on June/July pricing retention. The market will likely place more value on evidence of durable 3Q margins than on a single-quarter pricing windfall.
Intermediates & Derivatives produced $224 million of EBITDA in 1Q, but the result included roughly $40 million of impact from unplanned downtime at the Bayport PO/TBA facility.
For 2Q, LYB expected:
Management quantified the Bayport outage at roughly $25 million per week while down. Therefore, the actual restart timing, ramp quality, and residual outage cost will be crucial to understanding both 2Q results and 3Q run-rate earnings.
What to watch:
- Bayport restart date and whether the plant is now operating reliably;
- oxyfuel margin progression, especially in the U.S.;
- methanol, acetic acid, and VAM pricing realization; and
- the extent to which 2Q EBITDA missed potential earnings because of downtime.
The O&P-EAI segment was a meaningful drag in 1Q, with reported EBITDA of negative $35 million in the 10-Q. However, management’s adjusted view was less negative, and it expected improving polymer pricing, higher utilization, and better fixed-cost absorption in 2Q.
The completed sale of four European assets is strategically important:
LYB disclosed that it expected to record a pre-tax loss of approximately $700 million–$800 million tied to the sale, including an approximately $300 million cash contribution to the divested businesses and closing costs.
Implication: Investors should separate underlying EBITDA and cash economics from GAAP EPS. A large transaction-related charge could make headline earnings look weak even if the operating businesses perform very well.
Advanced Polymer Solutions delivered $58 million of EBITDA in 1Q, benefiting from seasonal volume recovery. For 2Q, the likely tension is between:
This is not likely to determine the quarter, but it matters for the credibility of LYB’s portfolio transformation and the resilience of earnings outside commodity polymers.
Technology EBITDA fell to $18 million in 1Q from $80 million in 4Q25, largely because fewer licensing milestones were recognized and catalyst demand weakened.
Management expected 2Q Technology results to be only slightly below 4Q25 levels as shipments and licensing milestones are recognized. That could make Technology a useful incremental tailwind to the quarter.
However, management also described demand for new licenses as historically weak amid slower global polyolefin capacity expansion. A 2Q rebound would therefore be more about revenue timing than evidence of a broad recovery in licensing demand.
LYB’s 1Q results illustrate why investors should look through GAAP noise:
| Metric | 1Q26 |
|---|---|
| Sales | $7.2B |
| Net income | $125M |
| Diluted EPS | $0.38 |
| Continuing-operations EPS | $0.42 |
| Reported EBITDA | $568M |
| Management-cited underlying EBITDA | $615M |
For 2Q, transaction charges from the European asset sale may further complicate EPS comparability. The cleanest scorecard will be:
LYB ended 1Q with:
Management had already reduced the quarterly dividend by 50% in early 2026, making clear that balance-sheet protection and debt repayment are higher priorities than buybacks or aggressive shareholder distributions.
For 2Q, a further working-capital build is likely because higher prices and volumes require more receivables and inventory investment. That is economically rational if margins are strong, but investors will want confirmation that higher EBITDA is converting to cash and not being fully absorbed by working capital.
Management’s 1Q message was unusually constructive: it argued that supply disruptions, logistics constraints, higher crude risk premiums, and potentially permanent capacity rationalization could support a steeper petrochemical cost curve for multiple quarters.
The buy-side debate is likely to center on whether this is:
Management’s answer on 3Q order books, pricing retention, export availability, industry operating rates, and customer demand will likely matter more for the stock than the reported 2Q EPS number.
LYB closed at $60.46 on July 30, 2026. The shares are down roughly 10% from their June 1 close, though they recovered almost 15% from the June 30 low into the report.
That setup suggests investors are acknowledging a better near-term earnings environment but remain skeptical about the duration of the uplift, the balance-sheet path, and the degree to which the company can convert improved market conditions into sustainable free cash flow.
The 2Q setup is favorable, with O&P-Americas the clearest earnings lever and I&D/Technology potential incremental contributors. The report should show a significant sequential improvement in underlying profitability. However, the highest-value information will be the forward outlook:
A report that confirms strong price capture, high U.S. utilization, a clean Bayport restart, and sustained 3Q supply tightness would support a materially stronger earnings-power narrative. A weaker read on price retention or a disappointing cash outlook would reinforce the view that 2Q is a transient cyclical peak rather than the beginning of a more durable recovery.